Bard Associates’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-6
| Closed | -$13K | – | 177 |
|
|
2018
Q2 | $13K | Hold |
6
| – | – | 0.01% | 172 |
|
|
2018
Q1 | $18K | Hold |
6
| – | – | 0.01% | 170 |
|
|
2017
Q4 | $29K | Sell |
6
-2
| -25% | -$9.67K | 0.01% | 168 |
|
|
2017
Q3 | $62K | Hold |
8
| – | – | 0.03% | 167 |
|
|
2017
Q2 | $37K | Hold |
8
| – | – | 0.02% | 178 |
|
|
2017
Q1 | $43K | Sell |
8
-2
| -20% | -$10.8K | 0.02% | 176 |
|
|
2016
Q4 | $67K | Sell |
10
-1
| -9% | -$6.7K | 0.03% | 165 |
|
|
2016
Q3 | $160K | Sell |
11
-1
| -8% | -$14.5K | 0.08% | 152 |
|
|
2016
Q2 | $181K | Hold |
12
| – | – | 0.1% | 148 |
|
|
2016
Q1 | $248K | Hold |
12
| – | – | 0.14% | 132 |
|
|
2015
Q4 | $247K | Sell |
12
-1
| -8% | -$20.6K | 0.15% | 126 |
|
|
2015
Q3 | $258K | Buy |
+13
| New | +$258K | 0.15% | 125 |
|